Pacific Biosciences of California Inc
Research Pacific Biosciences of California Inc (PACB) on Bullrun: market cap USD 472.43M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPACB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 472.43M
- Financial periodQ2 2026
- RevenueUSD 39.01M
- Net income-USD 44.74M
- Free cash flow-USD 39.19M
- Gross margin32.4%
Valuation Snapshot
latest market cap is USD 472.43M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 160.01M | -USD 546.40M | -USD 113.92M | 28.6% | -1.82 | USD 63.71M | USD 702.42M | USD 5.35M |
| FY2024 | USD 154.01M | -USD 309.90M | -USD 212.25M | 24.2% | -1.59 | USD 55.37M | USD 0 | USD 506.59M |
| FY2023 | USD 200.52M | -USD 306.70M | -USD 268.02M | 26.3% | -1.21 | USD 179.91M | USD 490.00K | USD 701.30M |
| FY2022 | USD 128.30M | -USD 314.20M | -USD 279.96M | 38.2% | -1.4 | USD 325.09M | USD 898.53M | USD 562.90M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 472.43M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 564.66M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 538.78M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.62B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.85B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 4.52B | n/a | n/a | n/a |
About Pacific Biosciences of California Inc
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Pacific Biosciences of California Inc's market cap?
Pacific Biosciences of California Inc's market capitalization is USD 472.43M.
What does Pacific Biosciences of California Inc do?
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases.